Keyphrases
Anemia
100%
Congestive Heart Failure
96%
Chronic Kidney Disease
85%
Erythropoietin
67%
Intravenous Iron
64%
Prognostic Value
64%
Medical Patients
64%
Diagnostic Value
64%
Hospitalization
45%
COVID-19 Patients
42%
Emergency Department
32%
Non-diabetic
32%
Lactate Dehydrogenase
32%
D-penicillamine
32%
Readmission
32%
Serum Lactate Dehydrogenase
32%
Home Therapy
32%
Concurrent Diagnoses
32%
Thrombocytosis
32%
Severe COVID-19 Patients
32%
Diabetic
32%
Diagnostic Delay
32%
Heart Failure
32%
Breast Enlargement
32%
Early Discharge
32%
Aggressive Therapy
32%
Renal Failure
32%
Discharge Strategies
32%
Intervention Group
32%
Blood Culture
32%
Antibiotic Administration
32%
Single-center Study
32%
Culture Positivity
32%
Palliative Extubation
32%
COVID-19
30%
Scleroderma
24%
Confidence Interval
22%
Hospital Stay
21%
30-day Mortality
21%
Respiration
21%
Antibiotics
20%
Hemoglobin
19%
Adjusted Odds Ratio
18%
Mild Anaemia
16%
Independent Predictors of Mortality
16%
Enlargement
16%
Adverse Effects
16%
In-hospital Outcomes
15%
Delta Variant
15%
Moderate to Severe
12%
Medicine and Dentistry
Anemia
67%
COVID-19
64%
Diagnosis
64%
Disease
60%
Congestive Heart Failure
59%
Chronic Kidney Disease
50%
Drug Therapy
40%
Erythropoietin
35%
Heart Failure
34%
Emergency Department
32%
Breast Enlargement
32%
Home Oxygen Therapy
32%
Lactate Dehydrogenase
32%
Penicillamine
32%
Diagnostic Delay
32%
Thrombocytosis
32%
Renal Failure
32%
Extubation
32%
Attitude
32%
Chronic Disease
32%
Scleroderma
24%
Infection
22%
Odds Ratio
18%
Adverse Event
16%
Biological Marker
12%
Diagnostic Procedure
8%
Breast Reduction
8%
Artificial Respiration
7%
Mortality Rate
7%
Iron Sucrose
7%
Prevalence
7%
Hematologic Malignancy
6%
Final Diagnosis
6%
Rheumatic Disease
5%
Cancer
5%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
99%
Congestive Heart Failure
91%
Disease
84%
Chronic Kidney Failure
82%
Erythropoietin
67%
Antibiotics
32%
Lactate Dehydrogenase
32%
Diabetes Mellitus
32%
Heart Failure
32%
Kidney Failure
32%
Thrombocytosis
32%
Penicillamine
32%
Infection
27%
Scleroderma
24%
Mortality Rate
19%
Antibiotic Agent
18%
Adverse Event
16%
Disease Severity
16%
Acute Kidney Failure
16%
Adverse Outcome
16%
Population Study
16%
Delta Variant
16%
Biological Marker
12%
Iron Saccharate
10%
Terminal Disease
8%
Prevalence
7%
Hematologic Malignancy
6%
Inflammation
5%
Rheumatic Disease
5%
